Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Eliquis (apixaban) , Bristol-Myers Squibb and Pfizers Factor Xa inhibitor and among the highest-revenue drugs in the U.S., has compound patents that began expiring in 2026, with complex patent litigation determining the precise entry timeline for generics [37]
)
Theoretical potential benefits (currently unproven for rheumatoid arthritis and not studied at microdose levels): Possible anti-inflammatory effects through modulation of immune pathways Weight reduction, which may indirectly benefit joint symptoms in overweight patients Cardiovascular risk reduction, relevant given increased cardiovascular disease risk in rheumatoid arthritis (established in type 2 diabetes populations at therapeutic doses only) [28] Improved metabolic parameters in patients with concurrent metabolic syndrome Known adverse effects of GLP-1 receptor agonists at standard doses include: Gastrointestinal symptoms : nausea, vomiting, diarrhoea, constipation, and abdominal discomfort (very common, affecting more than 1 in 10 patients) Hypoglycaemia : particularly when used with other glucose-lowering medications Injection site reactions : erythema, pruritus, or nodules Pancreatitis : rare but serious, requiring immediate medical attention if severe abdominal pain develops Gallbladder disease : increased risk of cholelithiasis and cholecystitis Thyroid effects : thyroid C-cell tumours observed in rodents
Protects skin from free radicals that cause skin damage
Known as the triple G obesity drug, retatrutide works differently from existing weight loss injections by targeting not just one, but three important hormone pathways in your body
.webp)
This persistent inflammation leads to ulcers and erosions that frequently bleed, ranging from mild spotting to severe haemorrhage requiring hospitalisation
)
)
)
)
